Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CRAFT FCF 31:01
- Development stage
- Unknown
- Lead developer
- DEMECAN
- Modality
- Small Molecules
- Administration
- Inhalation, Oral
01
Overview
CRAFT FCF 31:01 is a medical cannabis flower product distributed by DEMECAN and cultivated by Millcreek Growth in Canada. It is an unbestrahlt (unirradiated) Indica-dominant hybrid strain derived from the First Class Funk cultivar, which is a genetic cross between GMO (Garlic Cookies) and Jet Fuel Gelato. The product features a high tetrahydrocannabinol (THC) content of approximately 28.9% to 30.7% and less than 1% cannabidiol (CBD). It is prescribed in Germany for the treatment of chronic pain, sleep disorders, ADHD, migraine, headache, and inflammatory conditions. The therapeutic effects are mediated through the activation of cannabinoid receptors (CB1 and CB2) by THC and other cannabinoids, as well as synergistic interactions with dominant terpenes such as limonene, beta-caryophyllene, myrcene, and pinene.
- Brand names
- CRAFT FCF 31:01Demecan CRAFT FCF 31:01
- Other names
- CRAFT FCF 31/1CRAFT First Class Funk 31:1Demecan CRAFT FCF 31/1Demecan CRAFT First Class Funk 31:1First Class Funk
02
Targets
CNR1 (Cannabinoid receptor 1)
Beyond the preview
Go deeper on CRAFT FCF 31:01.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CRAFT FCF 31:01.